152 AttackMS natalizumab for the treatment of people with inflammatory demyeli- nation suggestive of multiple sclerosis

Research output: Contribution to conference › Conference paper (not formally published) › peer-review

Access to Document

@conference{36ab7377a3b74f968b5a0896285e2e76,

title = "152 AttackMS natalizumab for the treatment of people with inflammatory demyeli- nation suggestive of multiple sclerosis",

author = "K Schmierer and I Redha and V Hammond and D Baker and F Barkhof and R Hooper and W Rashid and V Singh-Curry and J Hobart and G Giovannoni",

year = "2022",

month = sep,

doi = "10.1136/jnnp-2022-abn2.196",

language = "English",

}

TY - CONF

T1 - 152 AttackMS natalizumab for the treatment of people with inflammatory demyeli- nation suggestive of multiple sclerosis

AU - Schmierer, K

AU - Redha, I

AU - Hammond, V

AU - Baker, D

AU - Barkhof, F

AU - Hooper, R

AU - Rashid, W

AU - Singh-Curry, V

AU - Hobart, J

AU - Giovannoni, G

PY - 2022/9

Y1 - 2022/9

U2 - 10.1136/jnnp-2022-abn2.196

DO - 10.1136/jnnp-2022-abn2.196

M3 - Conference paper (not formally published)

ER -